Telazorlimab
Telazorlimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Telazorlimab is under investigation in clinical trial NCT03568162 (Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis).
| Trade Name | Telazorlimab |
| Generic | Telazorlimab |
| Telazorlimab Other Names | Telazorlimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Telazorlimab
